
Pendri Kiran Reddy
About Pendri Kiran Reddy
Data last updated:
Pendri Kiran Reddy is a Director at Escientia Advanced Sciences Private Limited (since 2013) and Director at Escientia Biopharma Private Limited (since 2008). The companies operate in Pharma, Environment and Home & Lifestyle. The 2 current companies with reported revenue have a combined latest revenue of ₹443 Cr; the largest is Escientia Advanced Sciences Private Limited at ₹423 Cr (FY 2024). Earlier, Pendri Kiran Reddy was an Additional Director at Atchutapuram Effluent Treatment Limited (2019) and Director at Laxman Logistics Private Limited (2012–2013) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Feb 2013 | 2013 | ₹423 Cr (FY 2024) | Active | |
| Director | 10 Nov 2008 | 2008 | ₹20.04 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 26 Jun 2019 | 2016 | ₹1.1 Lakh (FY 2019) | Active | |
| Director | 02 Apr 2012 | 2009 | ₹2.43 Cr (FY 2017) | Amalgamated | |
| Director | 08 Feb 2010 | 2010 | ₹20.71 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pendri Kiran Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajit Alexander George | 10077248 | Escientia Advanced Sciences Private Limited , Escientia Biopharma Private Limited | Director |
| Dandu Chakradhar | 07328978 | Escientia Advanced Sciences Private Limited , Escientia Biopharma Private Limited | Director |
| Srinivasa Rao Korada | 07027842 | Escientia Advanced Sciences Private Limited | Cfo |
| Srinivasa Rao Korada | Escientia Advanced Sciences Private Limited | Cfo | |
| Vivek Vasant Save | 05191822 | Escientia Advanced Sciences Private Limited , Escientia Biopharma Private Limited | Director |
| Yadagiri R Pendri | 01966100 | Escientia Advanced Sciences Private Limited , Escientia Biopharma Private Limited | Director |
| Suresh Chandra Partani | 01941799 | Escientia Biopharma Private Limited | Director |
| Varadarajan Purushothaman | 01290407 | Escientia Biopharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pendri Kiran Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pendri Kiran Reddy
Pendri Kiran Reddy currently holds 2 directorships: Escientia Advanced Sciences Private Limited (Director, since 27 Feb 2013, revenue ₹423 Cr (FY 2024)); Escientia Biopharma Private Limited (Director, since 10 Nov 2008, revenue ₹20.04 Cr (FY 2025)).
Pendri Kiran Reddy was first appointed on 10 Nov 2008 as Director at Escientia Biopharma Private Limited. The most recent appointment on record is 26 Jun 2019 at Atchutapuram Effluent Treatment Limited.
The 2 current companies of Pendri Kiran Reddy that report revenue have a combined latest revenue of ₹443 Cr: Escientia Advanced Sciences Private Limited ₹423 Cr (FY 2024); Escientia Biopharma Private Limited ₹20.04 Cr (FY 2025).
Pendri Kiran Reddy held 3 earlier board appointments: Atchutapuram Effluent Treatment Limited (Additional Director, 26 Jun 2019 to 20 Sep 2019); Laxman Logistics Private Limited (Director, 02 Apr 2012 to 14 Nov 2013); Brattle Foods Private Limited (Director, 08 Feb 2010 to 14 Nov 2013).
The current boards of Pendri Kiran Reddy's companies include Ajit Alexander George (Escientia Advanced Sciences Private Limited), Dandu Chakradhar (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Vivek Vasant Save (Escientia Advanced Sciences Private Limited), Yadagiri R Pendri (Escientia Advanced Sciences Private Limited), among others.